These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 3566297)

  • 1. [Pharmacokinetic studies on THP-ADM (tetrahydropyranyl adriamycin)].
    Majima H
    Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 2):865-70. PubMed ID: 3566297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pharmacokinetic studies of THP-ADM (tetrahydropyranyl adriamycin)].
    Majima H; Iguchi H; Tone H
    Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 1):542-8. PubMed ID: 3954376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparative studies on the pharmacokinetics between THP and adriamycin in the same patients].
    Nakajima O; Imamura Y; Matsumoto A; Koyama Y; Shomura T; Kawamura K; Murata S
    Gan To Kagaku Ryoho; 1986 Feb; 13(2):261-70. PubMed ID: 3947106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic and pharmacodynamic advantages of pirarubicin over adriamycin after intraarterial hepatic administration in the rabbit VX2 tumor model.
    Munck JN; Riggi M; Rougier P; Chabot GG; Ramirez LH; Zhao Z; Bognel C; Ardouin P; Herait P; Gouyette A
    Cancer Res; 1993 Apr; 53(7):1550-4. PubMed ID: 8453622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical studies of (2''R)-4'-O-tetrahydropyranyl adriamycin (THP).
    Majima H; Ohta K
    Biomed Pharmacother; 1987; 41(5):237-43. PubMed ID: 3311190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A study on the correlation between the concentration of antitumor agent and the clinical effect. An experience with THP-ADM].
    Ogawa A; Yamashita K
    Gan To Kagaku Ryoho; 1985 Feb; 12(2):303-8. PubMed ID: 3970553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumor activity of (2''R)-4'-O-tetrahydropyranyl adriamycin on human gastric cancer cell lines in vitro and in vivo.
    Saikawa Y; Kubota T; Kuo TH; Furukawa T; Kase S; Tanino H; Ishibiki K; Kitajima M; Hoffman RM
    Anticancer Res; 1994; 14(2A):469-73. PubMed ID: 8017850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical study of THP-adriamycin in patients with advanced gastric cancer].
    Hayakawa M; Morise K; Ohno R; Saito H
    Gan No Rinsho; 1986 Jun; 32(7):762-8. PubMed ID: 3090301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Preliminary phase II clinical study of 4'-O-tetrahydropyranyl doxorubicin (THP-ADM)].
    Majima H
    Gan To Kagaku Ryoho; 1983 Mar; 10(3):805-10. PubMed ID: 6882000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical pharmacology and toxicity of 4'-O-tetrahydropyranyladriamycin.
    Miller AA; Schmidt CG
    Cancer Res; 1987 Mar; 47(5):1461-5. PubMed ID: 3815348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Flow cytometric analysis of the effect of THP-adriamycin on the cell cycle traverse of RPMI-8402 cells--comparison with adriamycin].
    Takamoto S; Ota K
    Gan To Kagaku Ryoho; 1986 May; 13(5):1868-75. PubMed ID: 3707149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 4'-O-tetrahydropyranyladriamycin has greater antineoplastic activity than adriamycin in various human tumours in vitro.
    Maehara Y; Sakaguchi Y; Kusumoto T; Kusumoto H; Sugimachi K
    Anticancer Res; 1989; 9(2):387-9. PubMed ID: 2751263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro antitumor activity of 4'-O-tetrahydropyranyladriamycin on human gastric cancer cells.
    Yamaue H; Tanimura H; Noguchi K; Shono Y; Iwahashi M; Hotta T; Tani M; Tsunoda T; Nishimoto N; Terasawa H; Nakamori M
    Anticancer Res; 1996; 16(1):243-6. PubMed ID: 8615614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic and tissue distribution changes of adriamycin and adriamycinol after intravenous administration of adriamycin to uranyl nitrate-induced acute renal failure rats.
    Lee HJ; Paik WH; Lee MG
    Res Commun Mol Pathol Pharmacol; 1996 Feb; 91(2):195-204. PubMed ID: 8832911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [THP-adriamycin in head and neck tumor].
    Honda T; Ohyama W; Sonoda T; Uchida K; Hirokawa T; Takada K; Takeda C
    Gan To Kagaku Ryoho; 1983 Dec; 10(12):2538-44. PubMed ID: 6651307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 4'-O-tetrahydropyranyladriamycin as a potential new antitumor agent.
    Tsuruo T; Iida H; Tsukagoshi S; Sakurai Y
    Cancer Res; 1982 Apr; 42(4):1462-7. PubMed ID: 7060020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative investigation on use of (2''R)-4'-O-tetrahydropyranyl-adriamycin and adriamycin as intravesical chemotherapy for superficial bladder tumors.
    Akaza H; Niijima T; Hisamatsu T; Fujigaki M
    Urology; 1988 Aug; 32(2):141-5. PubMed ID: 3400139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between the intracellular accumulation of anthracyclines and effectiveness in vitro and in vivo.
    Tapiero H; Munck JN; Fourcade A
    Drugs Exp Clin Res; 1986; 12(1-3):257-64. PubMed ID: 3460752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic and tissue distribution changes of adriamycin and adriamycinol after intravenous administration of adriamycin to alloxan-induced diabetes mellitus rats.
    Lee HJ; Paik WH; Lee MG
    Res Commun Mol Pathol Pharmacol; 1995 Aug; 89(2):165-78. PubMed ID: 8556271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between the intracellular level and growth inhibition of a new anthracycline 4'O-tetrahydropyranyl-Adriamycin in Friend leukemia cell variants.
    Munck JN; Fourcade A; Bennoun M; Tapiero H
    Leuk Res; 1985; 9(2):289-96. PubMed ID: 3990336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.